Ajanta Pharma has submitted its Sustainability Report for the financial year 2025, prepared in accordance with Global Reporting Initiative (GRI) Standards. This voluntary report supplements the previously submitted Business Responsibility and Sustainability Report (BRSR), outlining the company’s progress across environmental, social, and governance (ESG) parameters. The report highlights Ajanta Pharma’s commitment to responsible and sustainable growth.
Sustainability Report Submission
Ajanta Pharma has announced the submission of its Sustainability Report for the financial year 2025. The report was prepared following the standards set by the Global Reporting Initiative (GRI). This report offers additional insights into Ajanta Pharma’s dedication to sustainable and responsible business practices, going beyond regulatory compliance. This latest report is in addition to the Business Responsibility and Sustainability Report (BRSR) that was submitted earlier.
Key Areas of Focus
The Sustainability Report highlights various initiatives undertaken by Ajanta Pharma, focusing on achievements and progress made in key areas:
- Environmental Impact: Details on the company’s effort to minimize its ecological footprint.
- Social Responsibility: Insight into the company’s impact on society through various social initiatives.
- Governance Practices: Shows high standards of corporate governance and ethical practices.
This submission underscores Ajanta Pharma’s continuous commitment to sustainable growth by integrating responsible practices and setting benchmarks within the pharmaceutical industry.
Source: BSE
